Lu Tian
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression.
Journal: Hepatology (Baltimore, Md.)
Published: September 13, 2025
Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response.
Journal: Molecular cancer
Published: October 15, 2024
GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC.
Journal: Hepatology (Baltimore, Md.)
Published: September 05, 2024
Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.
Journal: Cell death & disease
Published: August 21, 2024
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression.
Journal: Cancer letters
Published: March 27, 2024
Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications.
Journal: Hepatology (Baltimore, Md.)
Published: January 31, 2024
Extracellular vesicles and cancer stemness in hepatocellular carcinoma - is there a link?
Journal: Frontiers in immunology
Published: January 11, 2024
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Journal: Cellular and molecular gastroenterology and hepatology
Published: May 13, 2022
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1.
Journal: Cell & bioscience
Published: September 15, 2021
Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: June 16, 2021
Last Updated: 09/26/2026